In patients with isolated hypercholesterolemia previously not treated with any hypolipidemic drugs treatment with alirocumab decreased PAI-1 antigen, F VII activity and fibrinogen concentration [47]. The gene discussed is SERPINE1; the disease is Hypercholesterolemia.